Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of Fluticasone Furoate/Vilanterol in COPD Exacerbations
NCT01017952Phase 3Completed
- Sponsor
- GSK
- Start
- Sep 2009
- Primary completion
- Oct 2011
- Modality
- Orthosteric Ligands
- Countries
- 15
01
Overview
A Phase 3 trial of fluticasone in chronic obstructive pulmonary disease (COPD), sponsored by GSK. Started Sep 2009; status: completed.
02
Drugs
fluticasone
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT01017952.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01017952.